Published in Medical Letter on the CDC and FDA, January 8th, 2006
Xyrem is marketed in the European Union by UCB, which announced the product's availability in Germany.
Narcolepsy is a debilitating neurological disorder. Cataplexy is a typical symptom of narcolepsy, second in frequency only to excessive daytime sleepiness. Cataplexy is a sudden loss of control over voluntary muscles, usually triggered by emotions such as amusement, anger, arousal or fear. Severe cataplexy attacks can cause...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA